ArticleCureus2025
Refractory Ventricular Arrhythmias in Thyrotoxic Periodic Paralysis: An Uncommon Presentation of Cardiogenic Shock.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Thyrotoxic periodic paralysis (TPP) is a rare complication of hyperthyroidism, often seen in young males, characterized by acute flaccid paralysis due to intracellular potassium shifts. While most cases present with isolated muscle weakness, progression to thyroid storm with life-threatening arrhythmias and multiorgan failure is exceedingly rare. We present the case of a previously healthy 23-year-old male who arrived with profound weakness and was found to have severe hypokalemia and suppressed thyroid-stimulating hormone (TSH). Shortly after arrival, he developed ventricular fibrillation and suffered prolonged cardiac arrest, requiring nearly 90 minutes of cardiopulmonary resuscitation. He was placed on extracorporeal membrane oxygenation (ECMO) for refractory cardiogenic shock. His hospital course was further complicated by rhabdomyolysis, acute kidney injury requiring renal replacement therapy, and distal limb ischemia due to femoral cannulation, ultimately necessitating left above-knee amputation and right upper extremity fasciotomy. This case highlights the catastrophic potential of TPP and thyroid storm, the role of early ECMO support in refractory thyrotoxic arrhythmias, and the vascular risks associated with peripheral ECMO cannulation in the critically ill. Prompt recognition and aggressive support remain the cornerstone of survival in endocrine-driven cardiopulmonary collapse.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.